PD58: Bladder Cancer: Upper Tract Transitional Cell Carcinoma II

Podium Session Moderator(s)

• 

  Seth Lerner, MD

  Vice Chair for Faculty Affairs
  Baylor College of Medicine
• 

  Firas Petros, MD

  Urologic Oncologist
  The University of Toledo College of Medicine and Life Sciences

Presentations:

• 1:00 PM – 1:10 PM

  PD58-01: Prevalence and Spectrum of Germline Mutations in Patients with Upper Tract Urothelial Carcinoma
  

  Podium Presenter: Hong Truong, MD, MS
• 1:10 PM – 1:20 PM

  PD58-02: Novel Use of ctDNA to Identify Locally Advanced and Metastatic Upper Tract Urothelial Carcinoma
  

  Podium Presenter: Heather L. Huelster, MD – Moffitt Cancer Center
• 1:20 PM – 1:30 PM

  PD58-03: Detection of individualized mutation using plasma and urinary circulating tumor DNA in patients with upper tract urothelial carcinoma
  

  Podium Presenter: Daichi Tamura, MD – Iwate Medical University
• 1:30 PM – 1:40 PM

  PD58-04: A Comprehensive Liquid Biopsy to Detect Primary Upper Tract Urothelial Carcinoma: A Pilot Study
  

  Podium Presenter: Alireza Ghoreifi, MD – USC
• 1:40 PM – 1:50 PM

  PD58-05: Final Results of a Phase I Trial of WST11 (TOOKAD Soluble) Vascular-Targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma
  

  Podium Presenter: Wesley Yip, MD
• 1:50 PM – 2:00 PM

  PD58-06: Antegrade Administration of Reverse Thermal Mitomycin Gel for Primary Chemoablation of Upper Tract Urothelial Carcinoma via Percutaneous Nephrostomy Tube: a Multi-Institutional Real-World Experience
  

  Podium Presenter: Kyle M. Rose, MD,MS
• 2:00 PM – 2:10 PM

  PD58-07: Impact of Node Count on Survival Outcomes of Lymph Node Dissection in non-Metastatic Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry
  

  Podium Presenter: Kevin Hakimi, BS – University of California San Diego
• 2:10 PM – 2:20 PM

  PD58-08: Survival Outcomes in Solitary Kidney Patients Diagnosed with Upper Tract Urothelial Carcinoma
  

  Podium Presenter: Ridwan I. Alam, MD,MPH
• 2:20 PM – 2:30 PM

  PD58-09: Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper Tract Urothelial Carcinoma of the Ureter Compared to Radical Nephroureterectomy
  

  Podium Presenter: Marco Paciotti, MD
• 2:30 PM – 2:40 PM

  PD58-10: Implementing the follow-up Schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma
  

  Podium Presenter: Alberto Martini, MD – San Raffaele University
• 2:40 PM – 2:50 PM

  PD58-11: Impact of Pre-operative Kidney Function on Survival Outcomes in Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry
  

  Podium Presenter: Kevin Hakimi, BS – University of California San Diego
• 2:50 PM – 3:00 PM

  PD58-12: Cross-reactivity between the first-line chemotherapy and subsequent immunotherapy in patients with unresectable or metastatic urothelial carcinoma
  

  Podium Presenter: Tomoko Hamaya